Pervasive secrecy kept even high-ranking people at the blood-technology startup in the dark, former employees said in testimony at Elizabeth Holmes’s criminal-fraud trial.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
